ARAY - Accuray Incorporated
| Previous Close | 2.9700 |
| Open | 2.8900 |
| Bid | 2.7000 x 2200 |
| Ask | 2.9700 x 1100 |
| Day's Range | 2.8900 - 3.0477 |
| 52 Week Range | 2.3500 - 5.2100 |
| Volume | 602,828 |
| Avg. Volume | 647,866 |
| Market Cap | 268.235M |
| Beta (5Y Monthly) | 1.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0140 |
| Earnings Date | Apr 20, 2020 - Apr 26, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.38 |
- Zacks
Why Is Accuray (ARAY) Down 28.2% Since Last Earnings Report?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4
Avanos (AVNS) gains from segmental contributions in Q4.
- Zacks
OPKO Health (OPK) Q4 Loss Narrower Than Estimates, Sales Up
OPKO (OPK) gains from increase in RAYALDEE prescriptions.
- Zacks
LHC Group (LHCG) Q4 Earnings Meet Estimates, Revenues Lag
LHC Group (LHCG) fourth-quarter results benefit from home health and hospice admissions and higher revenues.
- Zacks
Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y
Patterson Companies' (PDCO) fiscal third-quarter results benefit from higher revenues and solid show by Dental as well as Animal Health segments.
- Zacks
Nevro (NVRO) Q4 Loss Narrower Than Expected, Revenues Up Y/Y
Nevro (NVRO) sees strong segmental contributions in Q4.
- Zacks
Orthofix (OFIX) Q4 Earnings Match Estimates, Margins Decline
We are upbeat about the year-over-year revenue growth recorded by majority of Orthofix's (OFIX) key operating segments in Q4.
- Zacks
Inogen's (INGN) Q4 Earnings Miss, Revenues Top Estimates
Inogen (INGN) sees segmental softness in the fourth quarter.
- Zacks
Penumbra (PEN) Q4 Earnings Beat Estimates, Margins Expand
Penumbra (PEN) registers balanced segmental growth across all geographies in Q4.
- Zacks
Merit Medical (MMSI) Q4 Earnings & Revenues Beat Estimates
Merit Medical's (MMSI) fourth-quarter results gain from higher revenues and solid segmental performance benefit. However, contraction in gross margin remains a concern.
- PR Newswire
First Accuray CyberKnife® M6™ System Installed in Missouri at Mercy Hospital St. Louis
Accuray Incorporated (NASDAQ: ARAY) announced today that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife® M6™ System in Missouri at their state-of-the-art David C. Pratt Cancer Center. The next-generation CyberKnife System has been shown to deliver precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments with ease, making it possible for the clinical team to expand access to one of the most advanced methods for administering radiation to more cancer patients.
- Zacks
PRA Health (PRAH) Q4 Earnings and Revenues Beat Estimates
Solid Clinical Research revenues drove PRA Health's (PRAH) Q4 results.
- Zacks
HMS Holdings (HMSY) Q4 Earnings and Revenues Miss Estimates
HMS Holdings' (HMSY) fourth-quarter earnings benefit from higher revenues at Analytical Services unit and strong 2020 outlook.
- Zacks
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong segmental performance and solid 2020 EPS outlook.
- Zacks
Masimo (MASI) Q4 Earnings Beat Estimates, View Impressive
Masimo (MASI) sees expansion in gross and operating margin in Q4.
- Zacks
Integer Holdings (ITGR) Q4 Earnings & Revenues Top Estimates
Integer Holdings' (ITGR) fourth-quarter earnings benefit from higher revenues and strong segmental performance.
- Zacks
Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates
We are upbeat about the strong year-over-year revenue growth in the Clinical Solutions segment of Syneos Health (SYNH) in Q4.
- Zacks
Henry Schein (HSIC) Q4 Earnings and Revenues Top Estimates
Henry Schein (HSIC) registers solid performance by each of its key operating businesses in Q4.
- Zacks
Has Accuray (ARAY) Outpaced Other Medical Stocks This Year?
Is (ARAY) Outperforming Other Medical Stocks This Year?
- Zacks
The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx
The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx
- Zacks
Amedisys (AMED) Q4 Earnings Beat Estimates, Revenues Miss
Amedisys' (AMED) fourth-quarter earnings benefit from solid year-over-year growth in Medicare and non-Medicare revenues within Home Health.
- Zacks
Ecolab (ECL) Earnings and Revenues Miss Estimates in Q4
Strength in the Global Industrial arm drives Ecolab's (ECL) Q4 results.
- Zacks
Medtronic (MDT) Q3 Earnings Top Estimates, Revenues Miss
Medtronic (MDT) demonstrates better-than-expected Q3 performances at CER, backed by growth in all major business segments and geographies.
- Zacks
Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks
President Trump's tenure has seen Wall Street perform exceptionally well so far. In fact, Trump often cites Wall Street's bull run as a reflection of his good governance.
- Zacks
Change Healthcare (CHNG) Q3 Earnings Top Estimates, Down Y/Y
Change Healthcare's (CHNG) third-quarter fiscal earnings benefit from solid performance across the segments - Software and Analytics and Network Solutions. However, decline in revenues remains a woe.
